Join Our

Online Banking

Top Ten

Online Stock Trading

Bulletin Board

Stock Market Quotes

Gifts, Shopping

Pink Sheets

Page Builder

CME Globex2 Session

Live Chat Online Trading

Charts & Charting

Currency Rates

Free Auto-refreshin g Custom Pages!


Stock Picks

Real-time News Pages

Internet Lingo

Investment Books

Links Worlds Largest

Stock Quotes


Market Makers A-Z

Message Boards

News and Charts

Online Brokers W/ Phone Numbers

Options Information

Complete listing OTCBB Issues

Overseas Markets

Penny Stocks

S&P Fair Value

SI People & Subject

Site Map

Slang, Internet

Stock Markets

World Markets


Active Stocks


Privacy Policy

Affiliate Programs


NASCAR Schedule

PGA Schedule





OTC Markets Group Welcomes Quantum Genomics to OTCQX


NEW YORK, July 11, 2017 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC; OTCQX: QNNTF), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, has qualified to trade on the OTCQX® Best Market.   

Quantum Genomics begins trading today on OTCQX under the symbol "QNNTF."  U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on

"Trading on OTCQX will enable Quantum Genomics to provide U.S. investors with access to invest through a U.S. based, dollar denominated security. Allowing Quantum Genomics to expand its shareholder base and visibility in the U.S. market without incurring the high cost and duplicative regulatory requirements of a U.S. stock exchange listing.  We look forward to being part of Quantum Genomics' continued growth and success," said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group. 

"Quantum Genomics is very pleased to join the group of high quality international firms in the healthcare sector already trading on OTCQX. We believe trading on OTCQX will facilitate the access to our stock in the US market which is strategic for us, both operationally and financially," added Marc Karako, Director and CFO of Quantum Genomics.

Quantum Genomics was sponsored for OTCQX by Berns & Berns, a qualified 3rd party firm responsible for providing guidance on OTCQX requirements and recommending membership. 

Quantum Genomics is a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, especially hypertension and heart failure. The Company is developing a new therapeutic approach based on BAPAI (Brain Aminopeptidase A Inhibition). This is the result of more than 20 years of academic research in the laboratories of the Collège de France, INSERM, CNRS and the University of Paris Descartes. Quantum Genomics is listed on the Euronext Growth market in Paris (ISIN code FR0011648971, Ticker ALQGC) and trades on the OTCQX Best Market (OTCQX: QNNTF). The Company has offices in Paris, France, and New York, NY, USA.

About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX® Best Market, the OTCQB® Venture Market, and the Pink® Open Market for 10,000 U.S. and global securities.  Through OTC Link® ATS, we connect a diverse network of broker-dealers that provide liquidity and execution services.  We enable investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors.

To learn more about how we create better informed and more efficient markets, visit

OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.
Subscribe to the OTC Markets RSS Feed

Media Contact:
OTC Markets Group Inc., +1 (212) 896-4428,

View original content with multimedia:

SOURCE OTC Markets Group Inc.

Back to top

RELATED LINKS  Links  Search   Disclaimer  About Us Advertising

© 1995, 1996, 1997, 1998,1999, 2000, 2001 All rights reserved.